Related Experiment Video
Updated: Jan 2, 2026
08:36
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
1.1K
Correcting treatment effect for treatment switching in randomized oncology trials with a modified iterative
1Biostatistics and Research Decision Sciences, Merck Research Laboratories, 351 N. Sumneytown Pike, Upper Gwynedd, PA, 19454, U.S.A.
Statistics in Medicine
|February 27, 2016
Summary
This study introduces a modified iterative parametric estimation (MIPE) method to accurately analyze overall survival in oncology trials with patient crossover. MIPE offers a reliable alternative to the rank-preserving structural failure time (RPSFT) model for handling treatment effect confounding.
Area of Science:
- Biostatistics
- Clinical Trial Methodology
- Oncology Research
Background:
- Patient crossover from control to experimental arms in randomized oncology trials confounds overall survival analysis.
- Existing methods like rank-preserving structural failure time (RPSFT) are established, but iterative parametric estimation (IPE) properties are less understood.
- Ethical considerations and patient retention often necessitate allowing crossover after disease progression.
Purpose of the Study:
- To clarify and refine the iterative parametric estimation (IPE) method for analyzing overall survival in the presence of treatment crossover.
- To introduce a novel Modified Iterative Parametric Estimation (MIPE) method incorporating a specific re-censoring algorithm.
- To compare the performance of MIPE against the established RPSFT method.
Main Methods:
- Development of the Modified Iterative Parametric Estimation (MIPE) by incorporating a re-censoring algorithm into IPE.
- Extensive simulation studies to compare MIPE with the RPSFT model.
- Application of MIPE in a real-world clinical trial, including bootstrap analysis for variance and confidence interval estimation.
Main Results:
- The MIPE method, with the proposed re-censoring rule, demonstrated robust performance in simulations.
- MIPE was successfully applied to a real clinical trial, providing practical insights into its implementation.
- Bootstrap analysis confirmed MIPE's reliability in estimating variance and confidence intervals.
Conclusions:
- The Modified Iterative Parametric Estimation (MIPE) method is a statistically sound and practical alternative to RPSFT for analyzing overall survival in oncology trials with crossover.
- MIPE provides a valuable tool for researchers to accurately assess treatment effects when patient crossover occurs.
- Further adoption of MIPE is encouraged for improved analysis of complex clinical trial data.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
15.0K
09:44Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
10.5K
Related Concept Videos
01:20Comparing the Survival Analysis of Two or More Groups
510
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
510
01:21Cancer Survival Analysis
610
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
610
01:24Kaplan-Meier Approach
518
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
518
01:13Randomized Experiments
8.8K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
8.8K
01:14Parametric Survival Analysis: Weibull and Exponential Methods
950
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
950
01:11Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K